You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Constipation

Naldemedine for treating opioid-induced constipation

  • Technology appraisal guidance
  • Reference number: TA651
  • Published:  30 September 2020
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Declaration of interests
  2. Expected publication
  3. Final draft guidance
  4. Invitation to participate

History

Documents created during the development process.

Declaration of interests

  • Register of interests (PDF 127 KB)

    Published:
    30 September 2020

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 140 KB)

    Published:
    30 September 2020

Final draft guidance

  • Final draft guidance

  • Final appraisal document (PDF 283 KB)

    Published:
    27 August 2020
  • Committee papers (PDF 7.56 MB)

    Published:
    27 August 2020
  • Public committee slides (PDF 936 KB)

    Published:
    27 August 2020

Invitation to participate

  • Final stakeholder list (PDF 190 KB)

    Published:
    05 April 2019
  • Final scope (PDF 169 KB)

    Published:
    05 April 2019
  • Draft scope and provisional stakeholder list comments table (post-referral) (PDF 155 KB)

    Published:
    05 April 2019
  • Equality impact assessment (Scoping) (PDF 121 KB)

    Published:
    28 June 2019
Back to top